trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim
Thrombocytopenia complicates decisions regarding anticoagulation therapy in atrial fibrillation
the verdict
SUPPORTED
the evidence backs this
confidence 75/100

Thrombocytopenia complicates decisions regarding anticoagulation therapy in atrial fibrillation by creating a challenging balance between bleeding risks and thromboembolic prevention.

Evidence for · 2
Atrial fibrillation post hematopoietic stem cell transplant: incidence, risk factors, and management challenges.
2026 · cited by 0
Paper [0] explicitly states that management of atrial fibrillation is challenged by thrombocytopenia, complicating long-term decisions on anticoagulation.
See more details
More for · 1
Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia.
2026 · cited by 0
Paper [3] highlights that thrombocytopenia creates major therapeutic challenges when anticoagulant therapy is indicated for conditions like atrial fibrillation due to the dual hemostatic derangement.
The paper trail · every fact has a biography
first checked02 Aug 2026
judged → SUPPORTED · 7502 Aug 2026
This receipt carries no identity, shared or not. Sharing publishes your connection to it, not your data.
Check your own claim
Challenge the receipt
trust me, bro: win the argument, pass the class, survive peer review.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt